What is CBRE's health score?

CBRE GROUP, INC. (CBRE) has a TradeApes health score of 56 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CBRE's estimated fair value?

Based on our 5-year discounted cash flow model, CBRE GROUP, INC.'s estimated fair value is $110.69 per share, representing a -11.5% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is CBRE undervalued or overvalued?

Our model currently rates CBRE as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CBRE... Refresh in a moment for the full analysis.

CBRE GROUP, INC. (CBRE)

Real Estate Fair Value low mixed

$125.1

Updated: 2026-06-03

TradeApes Score

Financial Strength

55 Mixed

Operating Trend

55 Mixed

Relative Value

60 Healthy

Capital Allocation

45 Mixed

Risk

70 Healthy

Est. Fair Value $110.69

DCF Upside -11.5%

Sector Rank #1557 of 1843

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− High P/E — 25–45×, growth premium already priced in

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.